# MMR Vaccine
Who / What
The **MMR vaccine** is a combined immunization designed to protect against three infectious diseases: measles, mumps, and rubella (German measles). It merges the individual vaccines for these viruses into one dose, simplifying administration while maintaining high efficacy.
---
Background & History
Developed in the mid-20th century as part of global efforts to eradicate vaccine-preventable diseases, the MMR vaccine was first introduced commercially in the **1970s**. Early versions were adapted from earlier single-virus vaccines (e.g., measles and mumps) by combining live attenuated strains. The rubella component was added later to address outbreaks of congenital rubella syndrome. Key milestones include its widespread adoption in developed nations, leading to near-elimination of these diseases in many regions.
---
Why Notable
The MMR vaccine is notable for its **high efficacy**—two doses provide robust protection (97% against measles and rubella, 88% against mumps). It has played a critical role in public health by reducing mortality and long-term complications from these diseases. Additionally, its development exemplifies advancements in vaccine technology, enabling safer and more efficient immunization strategies.
---
In the News
Currently, the MMR vaccine remains a cornerstone of childhood vaccination programs worldwide. Recent developments include ongoing debates about misinformation (e.g., anti-vaccine movements) that have led to outbreaks in some regions despite its proven safety and effectiveness. Its relevance persists as global health organizations emphasize maintaining high immunization rates to combat resurgences of measles, particularly in areas with low coverage.
---
Key Facts
---
